Latest News
Featured News
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma
Result of 2024 Annual General Meeting
AGM Presentation 2024
Notice of Annual General Meeting October 2024
Scancell announces strengthening of leadership team as it closes on value-generating inflection points
SCOPE readouts in sight; SCIB1 data in Q424
Notice of AGM
Scancell Year End Results Presentation 2024
Scancell Preliminary Results for the Year Ended 30 April 2024
Scancell signs strategic partnership with PharmaJet for use of the Stratis® IM Needle-free delivery System in the development of SCIB1/iSCIB1+ cancer vaccine for Advanced Melanoma
Annual Meeting of the American Society of Clinical Oncology (ASCO), 31 May – 4 June 2024, Chicago, Illinois, USA
Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
